|
OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip |
0 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip |
|
|
OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package |
0 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package |
|
|
CAS MPDU_Build-2_Checklists |
0 |
|
CAS MPDU_Build-2_Checklists |
|
|
open_source_submission_checklist - OneVA Pharmacy CAS MPDU_Build_2.xlsx |
6 |
|
open_source_submission_checklist - OneVA Pharmacy CAS MPDU_Build_2.xlsx |
Report 1 |
|
product_build_checklist - OneVA Pharmacy CAS MPDU Build-2.docx |
7 |
|
product_build_checklist - OneVA Pharmacy CAS MPDU Build-2.docx |
Report 2 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_Documentation |
0 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_Documentation |
|
|
0001AK_CAS_MPDU_Version_Description_Document_20171212.docx |
9 |
|
0001AK_CAS_MPDU_Version_Description_Document_20171212.docx |
Report 3 |
|
0002AC OneVA Pharmacy Implementation SDD V3.2_20170630.docx |
≥1 |
|
0002AC OneVA Pharmacy Implementation SDD V3.2_20170630.docx |
Report 4 |
|
CAS_MPDU_Build_2_Requirements_User_Stories.docx |
13 |
|
CAS_MPDU_Build_2_Requirements_User_Stories.docx |
Report 5 |
|
OneVA_Pharmacy_CAS_MPDU_VistA_Patch_Build_Procedure.docx |
6 |
|
OneVA_Pharmacy_CAS_MPDU_VistA_Patch_Build_Procedure.docx |
Report 6 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_KIDS_Builds |
0 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_KIDS_Builds |
|
|
PSD_3_83_20171218A.KID |
0 |
|
PSD_3_83_20171218A.KID |
|
|
PSO_7_505_20171219A.KID |
0 |
|
PSO_7_505_20171219A.KID |
|
|
PSS_1_219_20171204B.KID |
0 |
|
PSS_1_219_20171204B.KID |
|
|
XU_8_689_20171124B.KID |
0 |
|
XU_8_689_20171124B.KID |
|
|
OneVA_Pharmacy_CAS_MPDU_Build-2_Patch_Descriptions |
0 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_Patch_Descriptions |
|
|
PSD_3_83_PD_20180108.txt |
3 |
|
PSD_3_83_PD_20180108.txt |
Report 7 |
|
PSO_5_505_PD_20180108.txt |
6 |
|
PSO_5_505_PD_20180108.txt |
Report 8 |
|
PSS_1_219_PD_20180108.txt |
3 |
|
PSS_1_219_PD_20180108.txt |
Report 9 |
|
XU_8_689_PD_20180108.txt |
3 |
|
XU_8_689_PD_20180108.txt |
Report 10 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases |
0 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases |
|
|
CAS_MPDU_TC_015_ Create new DEA # File.docx |
6 |
|
CAS_MPDU_TC_015_ Create new DEA # File.docx |
Report 11 |
|
CAS_MPDU_TC_016_Update New Person File to remove (hide) old fields in VistA.docx |
7 |
|
CAS_MPDU_TC_016_Update New Person File to remove (hide) old fields in VistA.docx |
Report 12 |
|
CAS_MPDU_TC_017_ Allow Multiple DEA Numbers to be associated to a Provider AddEdit Options in VistA.docx |
Error |
|
CAS_MPDU_TC_017_ Allow Multiple DEA Numbers to be associated to a Provider AddEdit Options in VistA.docx |
|
|
CAS_MPDU_TC_018_ Edit DEA number information from Non-VA Providers Profile in VistA.docx |
4 |
|
CAS_MPDU_TC_018_ Edit DEA number information from Non-VA Providers Profile in VistA.docx |
Report 13 |
|
CAS_MPDU_TC_019_ Remove DEA number information from Non-VA Providers Profile in VistA.docx |
5 |
|
CAS_MPDU_TC_019_ Remove DEA number information from Non-VA Providers Profile in VistA.docx |
Report 14 |
|
CAS_MPDU_TC_020_Remove DEA number without VA# information from Non-VA Providers Profile in VistA.docx |
Error |
|
CAS_MPDU_TC_020_Remove DEA number without VA# information from Non-VA Providers Profile in VistA.docx |
|
|
CAS_MPDU_TC_021_ DEA Number Technical Description.docx |
4 |
|
CAS_MPDU_TC_021_ DEA Number Technical Description.docx |
Report 15 |
|
CAS_MPDU_TC_022_ Prevent the use of the titrationmaintenance functionality on all controlled substance presc.docx |
Error |
|
CAS_MPDU_TC_022_ Prevent the use of the titrationmaintenance functionality on all controlled substance presc.docx |
|
|
CAS_MPDU_TC_023_Restrict Kernel Key PSDRPH allocation from being set up as un-auditable.docx |
≥1 |
|
CAS_MPDU_TC_023_Restrict Kernel Key PSDRPH allocation from being set up as un-auditable.docx |
Report 16 |
|
CAS_MPDU_TC_024_ Kernel key allocation to honor key delegation.docx |
≥1 |
|
CAS_MPDU_TC_024_ Kernel key allocation to honor key delegation.docx |
Report 17 |
|
CAS_MPDU_TC_025_ Orphan XU EPCS PSDRPH Key AllocateDe-Allocate.docx |
≥1 |
|
CAS_MPDU_TC_025_ Orphan XU EPCS PSDRPH Key AllocateDe-Allocate.docx |
Report 18 |
|
CAS_MPDU_TC_026_ Prevent dispensing of controlled substance prescriptions for patients without a Zip Code.docx |
Error |
|
CAS_MPDU_TC_026_ Prevent dispensing of controlled substance prescriptions for patients without a Zip Code.docx |
|
|
CAS_MPDU_TC_027_ Prevent edits of restricted fields on Controlled Substance Prescriptions.docx |
≥1 |
|
CAS_MPDU_TC_027_ Prevent edits of restricted fields on Controlled Substance Prescriptions.docx |
Report 19 |
|
CAS_MPDU_TC_028_Enhance Digitally Signed Control Substance Orders Report to include ECME Number.docx |
Error |
|
CAS_MPDU_TC_028_Enhance Digitally Signed Control Substance Orders Report to include ECME Number.docx |
|
|
CAS_MPDU_TC_029_ Add new filter option for Supplies for Complete Orders from OERR.docx |
≥1 |
|
CAS_MPDU_TC_029_ Add new filter option for Supplies for Complete Orders from OERR.docx |
Report 20 |
|
CAS_MPDU_TC_030_ Allow a secondary filter option.docx |
≥1 |
|
CAS_MPDU_TC_030_ Allow a secondary filter option.docx |
Report 21 |
|
CAS_MPDU_TC_031_ Allow leading zeros in prescription quantity.docx |
≥1 |
|
CAS_MPDU_TC_031_ Allow leading zeros in prescription quantity.docx |
Report 22 |
|
CAS_MPDU_TC_032_ Send indicator of digital signature for controlled substance prescriptions to Outpatient.docx |
Error |
|
CAS_MPDU_TC_032_ Send indicator of digital signature for controlled substance prescriptions to Outpatient.docx |
|
|
CAS_MPDU_TC_033_ Modify PSD DEA SUBOXONE Report to correct patient count logic..docx |
≥1 |
|
CAS_MPDU_TC_033_ Modify PSD DEA SUBOXONE Report to correct patient count logic..docx |
Report 23 |
|
CAS_MPDU_TC_034_ Modify the text of the email sent from ^PSOHLEXP routine for Expiring Facility DEA Number.docx |
Error |
|
CAS_MPDU_TC_034_ Modify the text of the email sent from ^PSOHLEXP routine for Expiring Facility DEA Number.docx |
|
|
CAS_MPDU_TC_035_ Manage dosage forms for pain use of buprenorphine-containing products.docx |
≥1 |
|
CAS_MPDU_TC_035_ Manage dosage forms for pain use of buprenorphine-containing products.docx |
Report 24 |
|
CAS_MPDU_TC_036_ Controlled Substance Order Management.docx |
≥1 |
|
CAS_MPDU_TC_036_ Controlled Substance Order Management.docx |
Report 25 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Delivery_Package_Content.docx |
5 |
|
OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Delivery_Package_Content.docx |
Report 26 |